Jade Anderson

29
Jul

Assay development designed for manufacture

During assay development, the feasibility stage is often viewed as a simple proof of concept. Can the assay detect its intended target? Are the initial results promising? And while these questions are fundamental, promising results alone don’t guarantee a successful path to commercialisation. Many assays perform well during initial development but can encounter challenges later because reproducibility and manufacturing requirements

Read more

17
Jul

Cell line authentication: A commercial provider’s perspective

Cell line authentication has long been recognised as a cornerstone of robust scientific research, yet misidentified and contaminated cell lines continue to undermine the reliability and reproducibility of published studies. Despite increasing awareness and the introduction of authentication guidelines, the question remains: how widespread is the problem in laboratories today? Our perspective on cell line authentication In our recent Frontiers

Read more

15
Jul

The true cost of a compromised cell line

Your cell lines are the foundation of your project. Whether you’re conducting biomedical research, drug discovery or therapeutic development, the reliability of your work depends on the quality and integrity of your cell lines. However, cell line contamination and misidentification remain among the most common challenges faced by laboratories worldwide. In fact, 33% of cell lines are misidentified or contaminated

Read more

27
Apr

Simplifying sample management from QC to storage

In research and development, your cell lines are among your most valuable assets. Yet the journey from qualification to long-term storage is often fragmented. Samples are frequently transferred between laboratories for testing and off-site storage facilities, introducing unnecessary risk at a critical stage of the research lifecycle. Safeguarding your assets shouldn’t be a logistical challenge. That’s why, at Biofortuna, we

Read more

1
Apr

Is your cell line QC process generating unnecessary carbon emissions?

It’s a question you may not have considered, but a growing number of outsourced cell line QC providers are sending samples overseas. At a time when global logistics are increasingly complex and sustainability is becoming an increasingly important consideration, this “standard” process is generating unnecessary carbon emissions and sending critical biological material abroad is increasingly difficult to justify. Beyond the

Read more

19
Jan

Safeguarding research integrity with STR profiling

The identity and purity of your cell lines are essential to the integrity of your research. Misidentified or contaminated cell lines lead to irreproducible data and costly errors, and without regular cell line authentication you risk wasting time and resources, potentially invalidating years of work. Regular cell line authentication through STR profiling offers a clear solution to verify cell line

Read more

18
Dec

A look back on 2025: Biofortuna’s highlights

2025 has been an incredible for Biofortuna, marked by continued collaboration with some of the most innovative influential companies within diagnostics, food safety, DNA testing and healthcare. We’ve done this while maintaining our focus on quality, reliability and innovation, delivering solutions that help bring life changing innovations to market faster. At the heart of this progress is our commitment to
Read more
10
Dec

Cell line characterisation

The cell line is the starting point for any application that relies on biology, including diagnostic manufacturing, academic discovery and biopharmaceutical development. Whether you’re conducting fundamental research, producing vaccines or diagnostic reagents, the quality and reliability of your cell line directly determines the efficacy, reproducibility and trustworthiness of your results or product. That’s why cell line characterisation is a critical,

Read more

28
Nov

3 essentials to consider when outsourcing GMO sample storage

Safe and compliant storage is crucial when working with Genetically Modified Organisms (GMOs). By outsourcing storage, organisations can free up laboratory space, reduce operational burden and focus on advancing their research. However, your choice of storage partner has a direct impact on regulatory compliance, sample safety and the success of your project, making it vital to select a provider you

Read more

19
Nov

Transferring lyophilised assays from development into manufacturing: Key Considerations

Transferring a lyophilised assay from development to large-scale manufacturing is never a simple matter of just “scaling up”. The lyophilisation process introduces challenges surrounding equipment, formulations, stability, validations and quality control. Each of these must be carefully considered to ensure consistency, reliability and compliance. Consideration 1: Freeze Dryer Capabilities One of the most notable hurdles in assay transfer is equipment.

Read more

Contact us